Cargando…

Gut Microbiota-driven Drug Metabolism in Inflammatory Bowel Disease

BACKGROUND AND AIMS: The gut microbiota plays an important role in the metabolization and modulation of several types of drugs. With this study we aimed to review the literature relating to microbial drug metabolism of medication prescribed in inflammatory bowel disease [IBD] practice. METHODS: A sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crouwel, Femke, Buiter, Hans J C, de Boer, Nanne K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904070/ https://www.ncbi.nlm.nih.gov/pubmed/32652007 http://dx.doi.org/10.1093/ecco-jcc/jjaa143

Ejemplares similares

Advances in Thiopurine Drug Delivery: The Current State-of-the-Art
por: Bayoumy, Ahmed B., et al.
Publicado: (2021)

Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?
por: van Andel, Emma M, et al.
Publicado: (2020)

Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series
por: Crouwel, Femke, et al.
Publicado: (2022)

The gut microbiota and inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2014)

Inflammatory Bowel Diseases and Gut Microbiota
por: Haneishi, Yuri, et al.
Publicado: (2023)

Gut Microbiota in Inflammatory Bowel Disease
por: Shim, Jung Ok
Publicado: (2013)

The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease—A Systematic Literature Review
por: Wiersma, Thomas K., et al.
Publicado: (2022)

Diet and microbiota in inflammatory bowel disease: The gut in disharmony
por: Rapozo, Davy C M, et al.
Publicado: (2017)

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
por: Simsek, Melek, et al.
Publicado: (2017)

Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
por: Sultan, Salma, et al.
Publicado: (2021)

Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
por: Hu, Yongjia, et al.
Publicado: (2022)

Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study
por: Jagt, Jasmijn Z., et al.
Publicado: (2021)

The Gut Microbiota in Inflammatory Bowel Disease
por: Qiu, Peng, et al.
Publicado: (2022)

Microbiota and Drug Response in Inflammatory Bowel Disease
por: Franzin, Martina, et al.
Publicado: (2021)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021)

Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease
por: Pavel, Flavia Maria, et al.
Publicado: (2021)

Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
por: Candelli, Marcello, et al.
Publicado: (2021)

The Nexus of Diet, Gut Microbiota and Inflammatory Bowel Diseases in Dogs
por: Rhimi, Soufien, et al.
Publicado: (2022)

Obesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic Syndrome
por: Cavalcante-Silva, Luiz H. A., et al.
Publicado: (2015)

Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease
por: Cao, Siyan “Stewart”
Publicado: (2018)

Role of metabolites derived from gut microbiota in inflammatory bowel disease
por: Zheng, Lie, et al.
Publicado: (2022)

The gut microbiota in mouse models of inflammatory bowel disease
por: Gkouskou, Kalliopi K., et al.
Publicado: (2014)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
por: Crouwel, Femke, et al.
Publicado: (2022)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
por: Zuo, Tao, et al.
Publicado: (2018)

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease
por: Segal, Jonathan P., et al.
Publicado: (2019)

Nicotinic Acetylcholine Receptor Involvement in Inflammatory Bowel Disease and Interactions with Gut Microbiota
por: Rueda Ruzafa, Lola, et al.
Publicado: (2021)

Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
por: Banfi, Davide, et al.
Publicado: (2021)

Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease
por: Fernández-Tomé, Samuel, et al.
Publicado: (2021)

The Intertwining Roads between Psychological Distress and Gut Microbiota in Inflammatory Bowel Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023)

Gut Microbiota, Inflammatory Bowel Disease, and Cancer: The Role of Guardians of Innate Immunity
por: Giambra, Vincenzo, et al.
Publicado: (2023)

Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review
por: Meijer, Berrie, et al.
Publicado: (2016)

Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018)

Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
por: Lazarević, Slavica, et al.
Publicado: (2022)

Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy
por: Seinen, Margien L., et al.
Publicado: (2016)

Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
por: Yang, Min, et al.
Publicado: (2021)

Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease
por: Markandey, Manasvini, et al.
Publicado: (2021)

Food Additives Associated with Gut Microbiota Alterations in Inflammatory Bowel Disease: Friends or Enemies?
por: Liu, Caiguang, et al.
Publicado: (2022)

Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
por: Alshehri, Dikhnah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ud1971o8gv79os1qm10itcu6n8